Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del<i>CFTR</i>Claire Wainwright, Michael Boyle, Susanna A. McColley et al.|New England Journal of Medicine|2015Cited by 1.6k
Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by <i>Mycobacterium avium</i> Complex (CONVERT). A Prospective, Open-Label, Randomized StudyDavid E. Griffith, Kevin Winthrop, Gina Eagle et al.|American Journal of Respiratory and Critical Care Medicine|2018Cited by 343
Pulmonary complications after esophagectomyChristopher E. Avendano, Carolyn E. Reed, Patrick A. Flume et al.|The Annals of Thoracic Surgery|2002Cited by 289
Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung DiseaseKenneth N. Olivier, Richard J. Wallace, David E. Griffith et al.|American Journal of Respiratory and Critical Care Medicine|2016Cited by 246
Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung DiseaseDavid E. Griffith, Kevin Winthrop, Rachel Thomson et al.|CHEST Journal|2021Cited by 52